Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Amador Bioscience
company
About
Amador Bioscience provides global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $60M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2018
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Amador Bioscience, a contract research organization (CRO) that provides global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$60M
Amador Bioscience has raised a total of
$60M
in funding over 2 rounds. Their latest funding was raised on
Dec 30, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 30, 2021 | Series B | $60M | 1 | — | — | Detail |
| Sep 28, 2021 | Series B | — | 1 |
Sequoia Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Amador Bioscience is funded by 1 investors.
Sequoia Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sequoia Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
